Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | PKLR | P30613 | 2/20 | 0.46 |
| ▸ | PARG | Q86W56 | 2/20 | 0.46 |
| ▸ | APEX1 | P27695 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29600607 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL517673 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL29445521 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL29352388 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL29490328 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL29561433 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL31059305 | 1.00 | ESR1 (0.50) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL2018087 | 0.98 | ESR1 (0.48) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL2154846 | 0.98 | ESR1 (0.48) | ESR1MAOAUGT1A1MAOBESR2 | |
| SCHEMBL5228890 | 0.98 | ESR1 (0.48) | ESR1MAOAUGT1A1MAOBESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 458 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587583-A1 | COVALENTLY MODIFIED TEMPLATE-INDEPENDENT DNA POLYMERASE AND METHODS OF USE THEREOF | The Charles Stark Draper Laboratory, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2025101956-A2 | CONTROL OF ENZYMATIC NUCLEIC ACID SYNTHESIS VIA ELECTROCHEMICAL MEANS | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| WO-2025034696-A2 | LOW CROSSOVER ION EXCHANGE MEMBRANES FOR REDOX FLOW BATTERIES | UNIVERSITY OF SOUTH CAROLINA (US) | 2025-02-13 | — | — | WO | claimed |
| CN-112151277-B | Electrolytic capacitor and method for manufacturing electrolytic capacitor | 松下知识产权经营株式会社 | 2025-01-10 | — | — | CN | claimed |
| US-20240429494-A1 | PLASMONIC PHOTOELECTRODES FOR PHOTOELECTROCHEMICAL REDOX FLOW BATTERIES | DEPARTMENT OF ENERGY | 2024-12-26 | — | — | US | claimed |
| CN-118518868-A | Immunosensor of vitamin B2, preparation method and application | 中芯维康医疗科技(重庆)有限责任公司 | 2024-08-20 | — | — | CN | claimed |
| WO-2024059703-A1 | COVALENTLY MODIFIED TEMPLATE-INDEPENDENT DNA POLYMERASE AND METHODS OF USE THEREOF | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| EP-2901520-B1 | SMALL ORGANIC MOLECULE BASED FLOW BATTERY | HARVARD COLLEGE (US) | 2023-11-29 | — | — | EP | claimed |
| US-11817554-B2 | Supercapacitor based on polymer electrolyte containing Mo(IV) doped hydrogel | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-11-14 | — | — | US | claimed |
| CN-113637503-B | Bimetallic FMG desulfurizing agent for wet oxidation desulfurization | 曲靖大为焦化制供气有限公司 | 2023-10-20 | — | — | CN | claimed |
| EP-1565530-A1 | PREPARATION OF BETA QUINACRIDONE PIGMENTS | Ciba SC Holding AG (CH) | 2005-08-24 | — | — | EP | claimed |
| US-6864371-B2 | Preparation of beta quinacridone pigments | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-03-08 | — | — | US | claimed |
| WO-2004067642-A1 | SYNTHESIS OF SMALL PARTICLE SIZE QUINACRIDONE OF BETA CRYSTAL PHASE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-08-12 | — | — | WO | claimed |
| US-20040138457-A1 | Preparation of beta quinacridone pigments | CIBA SPECIALTY CHEMICALS CORP. | 2004-07-15 | — | — | US | claimed |
| WO-2004048479-A1 | PREPARATION OF BETA QUINACRIDONE PIGMENTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-06-10 | — | — | WO | claimed |
| EP-0525073-B1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | DU PONT (US) | 1994-05-25 | — | — | EP | claimed |
| EP-0525073-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. | DU PONT (US) | 1993-02-03 | — | — | EP | claimed |
| WO-1991015954-A1 | ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| US-4455364-A | ETCHING RESISTANCE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-06-19 | — | — | US | claimed |
| US-4098667-A | Electrochemical method and device for producing oxygen | SOCIETE GENERALE DE CONSTRUCTIONS ELECTRIQUES ET MECANIQUES "ALSTHOM ET CIE" (FR) | 1978-07-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138457-A1 | Preparation of beta quinacridone pigments | PPOX, QDPR, NDUFB3 | ESR1 4837/4885MAOA 138/4885UGT1A1 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.